Osteoporosis in cushing's syndrome

Frontiers of Hormone Research

Volumn 30, Issue , 2002, Pages 60-72

  Kaltsas, Gregory ^a   Manetti, Luca ^a   Grossman, Ashley B ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CUSHING SYNDROME; HUMAN; OSTEOPOROSIS; PATHOPHYSIOLOGY; PREVALENCE; REVIEW;

CUSHING SYNDROME; HUMANS; OSTEOPOROSIS; PREVALENCE;

EID: 0036359769     PISSN: 03013073     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000061073     Document Type: Article

References (41)

1. Eastell R: Treatment of postmenopausal osteoporosis. N Engl J Med 1998;338:736-746.
2. Consensus Development Conference: Diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 1993;94:646-650.
3. Eastell R, Reid DM, Compston J, Cooper C, Fogelman I, Francis RM, Hoskinhg DJ, Purdie DW, Ralston SH, Reeve J, Russell RG, Stevenson JC, Torgerson DJ: A consensus group on management of glucocorticoid-induced osteoporosis: An update. J Intern Med 1998;244:271-292.
4. Reid IR, Grey AB: Corticoid osteoporosis. Baillières Clin Rheumatol 1993;7:573-587.
5. Newell-Price J, Trainer P, Besser M, Grossman A: The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states. Endocr Rev 1998;19:647-672.
6. Cushing H: The basophil adenomas of the pituitary body and their clinical manifestations. Bull Johns Hopkins Hosp 1932;50:137-195.
7. Dobnig H, Stepan V, Leb G, Wole G, Buchfelder M, Krejs GJ: Recovery from severe osteoporosis following cure from ectopic ACTH syndrome caused by an appendix carcinoid. J Intern Med 1996; 239:365-369.
8. Lane NE, Lukert B: The science and therapy of glucocorticoid-induced bone loss. Endocrinol Metab Clin North Am 1998;27:465-483.
9. Frost HM: The mechanostat: A proposed pathogenic mechanism of osteoporosis and the bone mass effects of mechanical and non-mechanical agents. Bone Miner 1987;2:73-86.
10. Kaplan FS, Leone VJC, Fallon MD, Hadda JG, Brihton CT, Steinberg ME: Multiple pathological fractures of the appendicular skeleton in a patient with Cushing's disease. Clin Orthop 1987;216:171-175.
11. Haddad JG, Kaplan F: Severe symptomatic osteopenia in a man with pigmented micronodular adrenal hyperplasia. Clin Orthop 1995;313:220-223.
12. Hough S, Teitelbaum SL, Bergfeld MA, Avioli LV: Isolated skeletal involvement in Cushing's syndrome: Response to therapy. J Clin Endocrinol Metab 1981;52:1033-1038.
13. Soffer LJ, Iannaccone A, Gabrilove JL: Cushing's syndrome: A study of fifty patients. Am J Med 1961;30:129-146.
14. Howland WJ, Pugh DG, Sprague RG: Roentgenologic changes in the skeletal system in Cushing's syndrome. Radiology 1968;71:69.
15. Ruder HJ, Loriaux DL, Lipsett MB: Severe osteopenia in young adults associated with Cushing's syndrome due to micronodular adrenal disease. J Clin Endocrinol Metab 1974;39:1138-1147.
16. Iannaccone A, Gabrilove JL, Brahms SA, Soffer LJ: Osteoporosis in Cushing's syndrome. Ann Intern Med 1960;52:570-586.
17. Leong GM, Mercado-Asis LB, Reynolds JC, Hill SC, Oldfield EH, Chrousos GP: The effect of Cushing's disease on bone mineral density, body composition, growth and puberty: A report of an identical adolescent twin pair. J Clin Endocrinol Metab 1996;81:1905-1911.
18. Manning PJ, Evans MC, Reid IA: Normal bone mineral density following cure of Cushing's syndrome. Clin Endocrinol 1992;36:229-234.
19. Sartorio A, Ambrosi B, Colombo P, Morabito F, Faglia G: Osteocalcin levels in Cushing's disease before and after treatment. Horm Metab Res 1988;20:70.
20. Piovesan A, Terzolo M, Reimondo G, Osella G, Boccuzi A, Paccoti P, Angeli A: Biochemical markers of bone and collagen turnover in acromegaly or Cushing's syndrome. Horm Metab Res 1994;26:234-237.
21. Sartorio A, Conti A, Ferrario S, Passini E, Re T, Ambrosi B: Serum bone Gla protein and carboxyterminal cross-linked telopeptide of type I collagen in patients with Cushing's syndrome. Postgrad Med J 1996;72:419-422.
22. Osella G, Terzolo M, Reimondo G, Piovesan A, Pia A, Termine A, Paccoti P, Angeli A: Serum markers of bone and collagen turnover in patients with Cushing's syndrome and in subjects with adrenal incidentalomas. J Clin Endocrinol Metab 1997;82:3303-3307.
23. Carnevale AV, Torlontano M, Fusili S, Guglielmi G, Modoni AS, Di Giorgio A, Liuzzi A, Minisola S, Cammisa M, Scillitani A: Alterations of bone turnover and bone mass at different skeletal sites due to pure glucocorticoid excess: Study of eumenorrheic patients with Cushing's syndrome. J Clin Endocrinol Metab 1998;83:1863-1867.
24. Di Somma C, Colao A, Pivonelo R, Klain M, Faggiano A, Tripodi FS, Merola B, Salvatore M, Lombardi G: Effectiveness of chronic treatment with alendronate in the osteoporosis of Cushing's disease. Clin Endocrinol 1998;48:655-662.
25. Gennari C: Glucocorticoid-induced osteoporosis. Clin Endocrinol 1998;41:273-274.
26. Canalis E: Mechanisms of glucocorticoid action in bone: Implications to glucocorticoid-induced osteoporosis. J Clin Endocrinol Metab 1996;81:3441-3447.
27. Nordin BEC: The systemic side effects of steroid therapy. Br J Dermatol 1960;72:40-47.
28. Hermus AD, Smals AG, Swinkels LM, Huysmans DA, Pieters GF, Fred-Swep C, Corstens FH, Kloppenborg PW: Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome. J Clin Endocrinol Metab 1995;80:2859-2865.
29. Nielsen KN, Charles P, Mosekilde L: The effect of single oral doses of prednisolone on the circadian rhythm of serum osteocalcin in normal subjects. J Clin Endocrinol Metab 1988;67: 1025-1030.
30. Aaron JE, Francis RM, Peacock M, Makins NB: Contrasting microanatomy of idiopathic and corticoid-induced osteoporosis. Clin Orthop Rel Res 1989;243:297-305.
31. Varanos S, Ansell BM, Reeve J: Vertebral collapse in juvenile chronic arthritis: Its relationship with corticosteroid therapy. Calcif Tissue Int 1987;41:75.
32. Lufkin EG, Wahner HW, Bergsralh EJ: Reversibility of steroid induced osteoporosis. Am J Med 1988;85:887-888.
33. Pocock NA, Eisman JA, Dunstan CR, Evans RA, Thomas DH, Huq NL: Recovery from steroidinduced osteoporosis. Ann Intern Med 1987;107:319-323.
34. Rizzato G, Montemurro L: The reversibility of exogenous corticosteroid-induced osteoporosis. Bone Miner 1992(suppl 1):141.
35. Laan RFJM, Van Riel PLCM, Van de Putte LBA, Van Erning LJ, Van'Thof MA, Lemmens JAM: Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. Ann Intern Med 1993;119:963-968.
36. Magiakou MA, Mastorakos G, Oldfield EH, Gomez MT, Doppman JL, Cutler GB Jr, Nieman LK, Chrousos GP: Cushing's syndrome in children and adolescents. N Engl J Med 1994;331:629-636.
37. Leong GM, Mercado-Asis LB, Reynolds JC, Parisi R, Nieman LK, Cutler GB Jr, Chrousos G: Endogenous Cushing's syndrome in children causes a marked decrease in bone mineral density and changes in markers of bone turnover that suggest suppression of both osteoblast and osteoclast activity. Proc Annu Meet Endocrinol Soc, 1995, abstr P2-592, p 438.
38. Reid IR: Pathogenesis and treatment of steroid osteoporosis. Clin Endocrinol 1989;30:83-103.
39. Maldaque B, Malghem J, Nagaant de Deuxchaisnes C: Radiologic aspects of glucocorticoidinduced bone disease. Adv Exp Med Biol 1984;171:155-190.
40. Freehill AK, Lenke LG: Severe kyphosis secondary to glucocorticoid-induced osteoporosis in a young adult with Cushing's disease. A case report and literature review. Spine 1999;24:189-193.
41. Luengo M, Picado C, Piera C, Guanabens N, Montserrat JM, Rivera J, Setoain J: Intestinal calcium absorption and parathyroid hormone secretion in asthmatic patients on prolonged oral or inhaled steroid treatment. Eur Respir J 1991;4:441-444.